Literature DB >> 18603048

Use of custom Dacron branch grafts for "hybrid" aortic debranching during endovascular repair of thoracic and thoracoabdominal aortic aneurysms.

G Chad Hughes1, Jeffrey J Nienaber, Errol L Bush, Mani A Daneshmand, Richard L McCann.   

Abstract

OBJECTIVES: A significant number of patients with thoracic and thoracoabdominal aortic aneurysms are unsuitable for endovascular repair owing to the absence of graft seal zones. "Hybrid" techniques, including open aortic debranching procedures, allow creation of proximal and/or distal landing zones and expand the potential applications of endovascular repair. We report our experience with aortic arch and thoracoabdominal debranching using custom fabricated Dacron branch grafts, which greatly simplify aortic debranching by providing inflow via a single anastomosis and incorporate a side arm for introduction of the stent graft.
METHODS: Between November 14, 2005, and December 18, 2006, a total of 53 thoracic endograft procedures were performed at our institution. Of these, 13 (25%) involved either open aortic arch or abdominal debranching to create proximal or distal landing zones for endovascular repair. Patients undergoing arch debranching (n = 7) had aneurysms involving the transverse arch with less than 2 cm of proximal landing zone distal to the innominate artery, necessitating stent graft coverage of both the innominate and left common carotid arteries. Patients undergoing complete abdominal debranching (n = 6) had either thoracoabdominal aortic aneurysms (extent II, n = 1; extent V, n = 3) or visceral button false aneurysms after prior open thoracoabdominal aortic aneurysm repair (n = 2). In all cases, endovascular aneurysm exclusion was performed at the same operation.
RESULTS: Mean patient age was 63 +/- 11 years (range 46-83 years); all patients had significant comorbidities, including prior open aortic surgery in 8 (62%). There were no perioperative (30 day) deaths and no permanent neurologic deficits, either cerebrovascular accident or paraparesis/paraplegia. At a mean follow-up of 7.5 +/- 6.0 months, there has been no late mortality and all debranching bypass grafts remain patent without need for further intervention. Computed tomographic scans demonstrate no type I or III endoleaks, and all aneurysms are thrombosed with stable (n = 4) or decreasing aortic dimensions (n = 9).
CONCLUSIONS: "Hybrid" aortic debranching using custom fabricated Dacron branch grafts with a single inflow source combined with endovascular aneurysm exclusion appears to be a safe alternative to conventional open repair for thoracoabdominal and arch aneurysms and avoids the need for cardiopulmonary bypass and aortic crossclamping. This technique may be ideally suited to patients with significant comorbidity or prior open aortic surgery. Longer term follow-up is needed to determine the durability of this approach.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18603048     DOI: 10.1016/j.jtcvs.2008.02.051

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  13 in total

1.  Endovascular therapy for thoracic aortic aneurysms: state of the art in 2012.

Authors:  Nicolas A Brozzi; Eric E Roselli
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-04

2.  Evolution of aortic arch repair.

Authors:  Joseph S Coselli; Susan Y Green
Journal:  Tex Heart Inst J       Date:  2009

3.  Evolving practice pattern changes and outcomes in the era of hybrid aortic arch repair.

Authors:  Ehsan Benrashid; Hanghang Wang; Jeffrey E Keenan; Nicholas D Andersen; James M Meza; Richard L McCann; G Chad Hughes
Journal:  J Vasc Surg       Date:  2015-10-27       Impact factor: 4.268

4.  Hybrid Three-Stage Repair for Extended Thoracoabdominal Aortic Aneurysm: Report of A Case.

Authors:  Kazuki Kihara; Kentaro Tamura; Genta Chikazawa; Taichi Sakaguchi; Toshinori Totsugawa; Hidenori Yoshitaka
Journal:  Ann Vasc Dis       Date:  2015-05-25

5.  Results of thoracic endovascular aortic repair 6 years after United States Food and Drug Administration approval.

Authors:  Asad A Shah; Michael E Barfield; Nicholas D Andersen; Judson B Williams; Julie A Shah; Jennifer M Hanna; Richard L McCann; G Chad Hughes
Journal:  Ann Thorac Surg       Date:  2012-07-10       Impact factor: 4.330

6.  Endovascular repair of descending thoracic aneurysms: results with "on-label" application in the post Food and Drug Administration approval era.

Authors:  G Chad Hughes; Sean M Lee; Mani A Daneshmand; Syamal D Bhattacharya; Judson B Williams; Sonny W Tucker; Richard L McCann
Journal:  Ann Thorac Surg       Date:  2010-07       Impact factor: 4.330

Review 7.  Review of Treatment for Thoracoabdominal Aortic Aneurysm, and the Modern Experience of Multi-Branched Endograft in Taiwan.

Authors:  Ting Chao Lin; Chun Che Shih
Journal:  Acta Cardiol Sin       Date:  2017-01       Impact factor: 2.672

8.  Combined open and endovascular repair for aortic arch pathology.

Authors:  Woong Chol Kang; Eak Kyun Shin; Tae Hoon Ahn; Kyung Hoon Lee; Chan Il Moon; Seung Hwan Han; Chul-Hyun Park; Kook-Yang Park; Jin Mo Kang; Jung Ho Kim
Journal:  Korean Circ J       Date:  2010-08-31       Impact factor: 3.243

9.  Complementary roles of open and hybrid approaches to thoracoabdominal aortic aneurysm repair.

Authors:  Ehsan Benrashid; Hanghang Wang; Nicholas D Andersen; Jeffrey E Keenan; Richard L McCann; G Chad Hughes
Journal:  J Vasc Surg       Date:  2016-07-18       Impact factor: 4.268

10.  Results with an algorithmic approach to hybrid repair of the aortic arch.

Authors:  Nicholas D Andersen; Judson B Williams; Jennifer M Hanna; Asad A Shah; Richard L McCann; G Chad Hughes
Journal:  J Vasc Surg       Date:  2012-11-24       Impact factor: 4.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.